A prominent healthcare entrepreneur from Chennai Dr GSK Velu highlighted that India's healthcare ... while India's role as ...

BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...

In an exclusive interview with Nigeria Health Watch, Dr Mukhtar outlined the Executive Order's two-year validity, and its transformative provisions. Central to this includes the removal of tariffs, ...

We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...

We're pleased to partner with Diabetes Singapore once again this year to champion healthy ageing in the community," said Raakhi Sippy, General Manager of GSK Singapore. Since its inception in 1971, ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK is leaving the biopharma trade group BIO, a spokesperson confirmed, the latest large pharma to back out of the group. “​​At this time, we believe there are other areas ...

The drugmaker’s U.S. plans comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% year ...

When Hurricane Helene damaged western North Carolina in September, filling medical facilities with people who couldn't be ...

His prior commercial experience also includes increasingly senior commercial roles at GSK, AstraZeneca and Biogen. “It’s a ...

Clinical study reports for the FURI, CARES and NATURE trials in refractory or resistant invasive fungal infections were delivered to GSK, ...

While uncertainty often casts a shadow on the Street, U.S. investors welcomed the presidential and congressional election results with a late-night surge that carried into this morning. The Dow Jones ...